Brevan Howard Capital Management’s Accendra Health ACH Stock Holding History

Brevan Howard Capital Management’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,635	Closed	-$29.8K	–	2387
2025 Q4	$29.8K	Sell	10,635 -190,460	-95%	-$681K	﹤0.01%	1708
2025 Q3	$965K	Buy	201,095 +69,379	+53%	+$441K	﹤0.01%	911
2025 Q2	$1.2M	Buy	131,716 +104,614	+386%	+$771K	0.01%	981
2025 Q1	$245K	Buy	27,102 +8,247	+44%	+$87.1K	﹤0.01%	923
2024 Q4	$246K	Buy	+18,855	New	+$251K	﹤0.01%	843
2024 Q3	–	Sell	-10,207	Closed	-$138K	–	1346
2024 Q2	$138K	Buy	+10,207	New	+$209K	﹤0.01%	943
2024 Q1	–	Sell	-17,678	Closed	-$341K	–	1257
2023 Q4	$341K	Sell	17,678 -41,034	-70%	-$743K	﹤0.01%	662
2023 Q3	$949K	Buy	+58,712	New	+$1.04M	0.01%	93

Other funds holding ACH

CCM

Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Brevan Howard Capital Management's ACH Position: Q1 2026 in Review

Brevan Howard Capital Management sold out of Accendra Health (ACH) in Q1 2026, closing a stake of 10,635 shares — an estimated $29.8K sold.

Brevan Howard Capital Management first reported a position in ACH in Q3 2023 and held it in 8 quarters. The position peaked at $1.2M in Q2 2025. 142 funds tracked by Wall St. Rank hold ACH as of Q1 2026.

Brevan Howard Capital Management reported no remaining Accendra Health position as of Q1 2026 after selling out during the quarter.
Brevan Howard Capital Management sold 10,635 Accendra Health shares in Q1 2026, an estimated $29.8K.
Brevan Howard Capital Management first reported a position in Accendra Health in Q3 2023 and held it in 8 quarters.
Brevan Howard Capital Management's Accendra Health position peaked at $1.2M in Q2 2025.
142 funds tracked by Wall St. Rank held Accendra Health as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.